% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • Optomistic__Two Optomistic__Two May 23, 2000 3:29 PM Flag

    Why is EXEL falling?

    I recognize that the market for this newbie will
    be volatile until something very concrete good or
    bad happens - maybe several years off. Still, the
    price adjustment in the past week seems way beyond
    anything else happening with biotech stocks. It makes me

    Are insiders now able to sell some of their stock,
    putting pressure on the price? Is this just a "normal"
    post-IPO adjustment? (I'm new to the IPO game.) Or is
    there something else going on?

    Any ideas to

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The lead underwriters on this issue were Goldman
      Sachs, CS First Boston, and SG Cowen. Most likely this
      issue was placed in institutional hands (as opposed to
      retail). Thus, it is probably institutions dumping this

      Reading the red herring, one of the company's competitors
      is LEXG (which hasn't done too well either). I
      forgot the other companies that the company mentioned
      that are its competitors.

    • I'm a a time like this you
      should buy some. This is just a market down fall thing.
      the only thing I can say about IPO is that look for
      adjustment after 6 months from IPO date. Meanwhile
      accumulate and hold in the short term a liiitle longer...

5.47-0.02(-0.36%)Nov 27 1:00 PMEST